Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jacob Wesley"'
Autor:
Christiane S. Hampe, Brianna D. Yund, Paul J. Orchard, Troy C. Lund, Jacob Wesley, R. Scott McIvor
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 15, p 7888 (2021)
Mucopolysaccharidosis (MPS) type I and II are two closely related lysosomal storage diseases associated with disrupted glycosaminoglycan catabolism. In MPS II, the first step of degradation of heparan sulfate (HS) and dermatan sulfate (DS) is blocked
Externí odkaz:
https://doaj.org/article/a573123ce15e4b0a8552678bdfabf6e1
Autor:
Christiane S. Hampe, Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cureoglu, Patricia Schachern, R. Scott McIvor
Publikováno v:
Biomolecules, Vol 11, Iss 2, p 189 (2021)
Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the glycosaminoglycans dermatan and heparan sulfate (DS and HS, respectively). Lack of the
Externí odkaz:
https://doaj.org/article/4f5fba414a974ed4a48d420d272de94a
Autor:
Christiane S. Hampe, Julie B. Eisengart, Troy C. Lund, Paul J. Orchard, Monika Swietlicka, Jacob Wesley, R. Scott McIvor
Publikováno v:
Cells, Vol 9, Iss 8, p 1838 (2020)
Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive inherited disease, caused by deficiency of the enzyme α-L-iduronidase, resulting in accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate in organs and tissues.
Externí odkaz:
https://doaj.org/article/2b5b1cd767f54850a959135cf7367b3d
Autor:
Stewart, Jacob Wesley
Heat stress is detrimental across many, if not most aspects of animal agriculture. Heat stress can have direct effects on the animal, effects on their environment and effects on the feedstuffs they consume. The work presented here will address direct
Externí odkaz:
http://hdl.handle.net/10919/107483
Autor:
Foshee, Jacob Wesley
We present a method for representing seams in clothing animation, and its application in simulation level of detail. Specifically we consider cloth represented as a regular grid of particles connected by spring-dampers, and a seam specified by a clos
Externí odkaz:
http://hdl.handle.net/1969.1/1226
Autor:
Sebahattin Cureoglu, Christiane S. Hampe, Troy C. Lund, Julie B. Eisengart, Linda K. McLoon, Paul J. Orchard, R. Scott McIvor, Jacob Wesley, Lynda E. Polgreen, Patricia A. Schachern
Publikováno v:
Biomolecules, Vol 11, Iss 189, p 189 (2021)
Biomolecules
Biomolecules
Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the glycosaminoglycans dermatan and heparan sulfate (DS and HS, respectively). Lack of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06dfc0026f88e1b728a3f4c4355f8bb2
https://www.mdpi.com/2218-273X/11/2/189
https://www.mdpi.com/2218-273X/11/2/189
Autor:
Troy C. Lund, Paul J. Orchard, Christiane S. Hampe, R. Scott McIvor, Jacob Wesley, Brianna Yund
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7888, p 7888 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 7888, p 7888 (2021)
Mucopolysaccharidosis (MPS) type I and II are two closely related lysosomal storage diseases associated with disrupted glycosaminoglycan catabolism. In MPS II, the first step of degradation of heparan sulfate (HS) and dermatan sulfate (DS) is blocked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9814651e95d11f352238eda9ed478053
https://doi.org/10.3390/ijms22157888
https://doi.org/10.3390/ijms22157888
Autor:
Kaushik Patra, Soraya Madani, Armando Flor, Gabriela Klodowska-Duda, Mark Agius, Jing Li, Maciej Maciejowski, Eliezer Katz, Andrzej Potemkowski, Gerard Barron, Jacob Wesley
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: B cells may be involved in the pathophysiology of multiple sclerosis (MS). Inebilizumab (formerly MEDI-551) binds to and depletes CD19+ B cells. Objectives: To assess safety, tolerability, pharmacokinetics, pharmacodynamics and immunogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56a5e7cbf80f7f5f4c3a9f537f11fca7
https://doi.org/10.1177/1352458517740641
https://doi.org/10.1177/1352458517740641
Publikováno v:
Journal of the American Ceramic Society. Jun2016, Vol. 99 Issue 6, p2197-2209. 13p.
Autor:
McMurray, Jacob Wesley1, Wong‐Ng, W.1
Publikováno v:
Journal of the American Ceramic Society. Mar2016, Vol. 99 Issue 3, p1092-1099. 8p. 3 Charts, 10 Graphs.